Equity Research, Broker Reports, and media content on Allergy Therapeutics

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Allergy Therapeutics
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Allergy Therapeutics. We currently have 180 research reports from 8 professional analysts.

Range Today
52 Week
Daily Volume
# Shares
Daily Liquidity
Pension Liability
Enterprise Value
Market Cap
Latest PE (hist)
Div Yield
Date Source Announcement
11Jul19 07:00 RNS Trading update
01Jul19 07:21 EQS Hardman & Co Research: Allergy Therapeutics (AGY): Successful legal outcome removes uncertainty
01Jul19 07:16 EQS Hardman & Co Research: Oxford BioMedica (OXB): Eying up long-term value
27Jun19 07:00 RNS Successful Litigation Settlement
27Jun19 07:00 RNS Trading Statement
19Jun19 07:00 RNS Board Change
11Jun19 07:00 RNS Holdings in Company
  • Frequency of research reports


  • Research reports on

    Allergy Therapeutics

  • Providers covering

    Allergy Therapeutics